Medical Device News Magazine

WaveGuide Corporation Launches World’s First Portable NMR Device

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

WaveGuide Corporation today launched its new WaveGuide Formµla™, the world’s only battery-powered, compact scientific instrument that performs rapid screening and diagnostics of solid and liquid substances spanning an array of markets and applications.

The WaveGuide Formla™ micro NMR delivers performance as good or better than larger, more costly benchtop NMRs, in a portable, easy-to-use device making it ideal for applications requiring in-situ decision making, including pharmaceutical, petrochemical, food quality, food safety, and consumer product authentication applications. The WaveGuide Formla™ provides quantitative analysis for a wide range of real-world scenarios—from detecting impurities in lubricants indicative of engine and component wear to authenticating biological therapies and vaccines to rapidly screening patients for specific disease states.

The WaveGuide Formla™ represents a significant departure from large, expensive, benchtop NMR solutions. In addition to trained operators, benchtop NMR systems can require up to 24 hours for the device and sample to temperature stabilize. The WaveGuide Formla™ requires minimal user training and little to no sample preparation. After a quick internal calibration, the instrument is ready to use within seconds.

The WaveGuide Formla™ will be launched at Pittcon 2020 booth #4911 in Chicago Illinois, March 2-5, 2020. A technical presentation, “Portable Forensic Analysis of Biological Agents and Consumer Products,” will be delivered by WaveGuide’s Head of Biology, Massimiliano La Colla Ph.D., at the conference on March 4.

“Until now, the size, cost and complexity of commercially available NMR platforms has limited their use to low volume and niche applications with high fixed costs. From WaveGuide’s founding in 2015, we have worked diligently to change this paradigm, partnering with Harvard University’s Department of Physics to pioneer a new class of micro NMR analyzer technology,” said Nelson K. Stacks, CEO and President of WaveGuide Corporation. “The WaveGuide Formla™ is truly a revolutionary development, opening the door to a range of in-situ applications in healthcare, consumer products, and industrial products that were previously impractical or impossible with the existing NMR technology.”

The WaveGuide Formla™ micro NMR is based on patented technology that enables small, low-cost, inhomogeneous magnets to produce a handheld chemical analyzer based on NMR, amplifying the NMR signal-to-noise by a factor of 10,000. WaveGuide has applied for six additional patents, bolstering the core technology.

More on the features and benefits can be found here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”